SyntekaBio Grants 180,000 Stock Options to Employees with Limited Dilution of 0.74%
On July 20, 2026, SyntekaBio granted 180,000 stock options to 10 employees through a board resolution.
The exercise price is 1,790 won, 12.6% above the current stock price of 1,590 won, representing a small dilution of 0.74% of total outstanding shares.
The options are exercisable from July 20, 2028 to July 19, 2031, with a two-year vesting period, and will be settled by issuing new shares.
The fair value per option is 1,034 won, calculated using a binomial model with volatility 80.9% and risk-free rate 4.11%.
[AI Summary]This stock option grant serves as an employee incentive with limited dilution impact on shareholder value. The options are currently out of the money but could become a dilution factor if the stock price rises above the exercise price in the future.